Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
APA | APA | Nov 27, 2024 | 22.52 | 0.00 |
Apartment Investment and Management | AIV | Nov 27, 2024 | 8.89 | -0.34 |
Apellis Pharmaceuticals | APLS | Nov 27, 2024 | 34.14 | +4.63 |
APi Group | APG | Nov 27, 2024 | 37.55 | -0.21 |
Apogee Enterprises | APOG | Nov 27, 2024 | 83.78 | -1.66 |
Apogee Therapeutics | APGE | Nov 27, 2024 | 44.70 | +1.68 |
Apollo Commercial Real Estate Finance | ARI | Nov 27, 2024 | 9.30 | +0.32 |
Apollo Global Management | APO | Nov 27, 2024 | 173.85 | -1.02 |
Apollomics A | APLM | Nov 27, 2024 | 8.16 | 0.00 |
AppFolio A | APPF | Nov 27, 2024 | 254.82 | -0.23 |
Appian A | APPN | Nov 27, 2024 | 37.09 | -1.54 |
Apple | AAPL | Nov 27, 2024 | 234.93 | -0.06 |
Apple Hospitality REIT | APLE | Nov 27, 2024 | 16.20 | +0.19 |
Applied Digital | APLD | Nov 27, 2024 | 9.66 | -0.82 |
Applied DNA Sciences | APDN | Nov 27, 2024 | 0.15 | -1.34 |
Applied Industrial Technologies | AIT | Nov 27, 2024 | 273.90 | -2.35 |
Applied Materials | AMAT | Nov 27, 2024 | 171.32 | -1.09 |
Applied Optoelectronics | AAOI | Nov 27, 2024 | 36.42 | -1.62 |
Applied Therapeutics | APLT | Nov 27, 2024 | 8.57 | -16.06 |
Applovin A | APP | Nov 27, 2024 | 328.56 | -0.37 |
AppTech Payments | APCX | Nov 27, 2024 | 0.46 | -1.71 |
Aprea Therapeutics | APRE | Nov 27, 2024 | 2.98 | +0.34 |
AptarGroup | ATR | Nov 27, 2024 | 171.73 | -0.18 |
Aptevo Therapeutics | APVO | Nov 27, 2024 | 0.35 | +2.77 |
Aptiv | APTV | Nov 27, 2024 | 55.52 | +0.43 |
Aptorum Group A | APM | Nov 27, 2024 | 0.71 | +5.49 |
Aptose Biosciences | APTO | Nov 27, 2024 | 0.18 | +0.56 |
APx Acquisition I A | APXI | Nov 27, 2024 | 11.89 | 0.00 |
APx Acquisition I Unit | APXIU | Nov 27, 2024 | 11.55 | 0.00 |
Apyx Medical | APYX | Nov 27, 2024 | 1.69 | +16.55 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.